NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free CLOV Stock Alerts $0.91 +0.09 (+10.95%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$0.82▼$0.9250-Day Range$0.62▼$0.8852-Week Range$0.61▼$1.63Volume16.13 million shsAverage Volume8.54 million shsMarket Capitalization$451.56 millionP/E RatioN/ADividend YieldN/APrice Target$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Clover Health Investments alerts: Email Address Clover Health Investments MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside64.5% Upside$1.50 Price TargetShort InterestBearish9.65% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.86Based on 13 Articles This WeekInsider TradingAcquiring Shares$100,010 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.20) to ($0.16) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.18 out of 5 starsMedical Sector570th out of 925 stocksHospital & Medical Service Plans Industry10th out of 11 stocks 3.0 Analyst's Opinion Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageClover Health Investments has received no research coverage in the past 90 days.Read more about Clover Health Investments' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted9.65% of the outstanding shares of Clover Health Investments have been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in Clover Health Investments has recently decreased by 0.73%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLOV. Previous Next 2.7 News and Social Media Coverage News SentimentClover Health Investments has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Clover Health Investments this week, compared to 2 articles on an average week.Search InterestOnly 26 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -82% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,010.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders21.82% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.77% of the stock of Clover Health Investments is held by institutions.Read more about Clover Health Investments' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Clover Health Investments are expected to grow in the coming year, from ($0.20) to ($0.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Clover Health Investments' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceDoes this chart look familiar?Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. About Clover Health Investments Stock (NASDAQ:CLOV)Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.Read More CLOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLOV Stock News HeadlinesMay 10 at 12:36 PM | finance.yahoo.comAnalysts Have Been Trimming Their Clover Health Investments, Corp. (NASDAQ:CLOV) Price Target After Its Latest ReportMay 9, 2024 | finance.yahoo.comClover Health Investments First Quarter 2024 Earnings: Beats ExpectationsMay 9, 2024 | finance.yahoo.comClover Health Investments Corp (CLOV) Q1 2024 Earnings Call Transcript Highlights: Strong Start ...May 9, 2024 | americanbankingnews.comClover Health Investments Target of Unusually High Options Trading (NASDAQ:CLOV)May 8, 2024 | msn.comHere’s why Clover Health stock price spiked after earningsMay 8, 2024 | investorplace.comCLOV Stock Earnings: Clover Health Investments Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | finance.yahoo.comClover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA ProfitabilityMay 7, 2024 | investorplace.com3 Healthcare Stocks to Sell in May Before They Crash & BurnMay 5, 2024 | americanbankingnews.comClover Health Investments (CLOV) to Release Quarterly Earnings on TuesdayMay 3, 2024 | morningstar.comClover Health Investments Corp Ordinary Shares - Class A CLOVMay 1, 2024 | finance.yahoo.comClover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads ConferenceApril 30, 2024 | globenewswire.comClover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)April 24, 2024 | finanznachrichten.deClover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial OfficerApril 23, 2024 | globenewswire.comClover Health to Report First Quarter 2024 Financial Results on May 7, 2024April 22, 2024 | marketwatch.comClover Health Names Peter Kuipers as New CFOApril 22, 2024 | globenewswire.comClover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial OfficerApril 9, 2024 | msn.comThe 26 Best Gym Bags For Your Workout EssentialsApril 6, 2024 | uk.investing.comClover Health settles shareholder lawsuits, enhances governanceApril 4, 2024 | globenewswire.comClover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative ActionsApril 4, 2024 | msn.comJMP starts HealthEquity at market outperform, cites revenue growthMarch 21, 2024 | markets.businessinsider.comCautious Optimism on Clover Health’s Performance with Concerns on Long-Term ProfitabilityMarch 20, 2024 | finance.yahoo.comInsider Spends US$110k Buying More Shares In Clover Health InvestmentsMarch 20, 2024 | investorplace.com3 Under-the-Radar Stocks to Transform $10K into $100K by 2028March 19, 2024 | globenewswire.comClover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental IllnessMarch 18, 2024 | finance.yahoo.comDowngrade: Here's How Analysts See Clover Health Investments, Corp. (NASDAQ:CLOV) Performing In The Near TermSee More Headlines Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today5/13/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Hospital & medical service plans Sub-IndustryN/A Current SymbolNASDAQ:CLOV CUSIPN/A CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees552Year FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$1.50 Low Stock Price Target$1.50 Potential Upside/Downside+71.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-213,360,000.00 Net Margins-8.63% Pretax Margin-8.46% Return on Equity-48.07% Return on Assets-16.63% Debt Debt-to-Equity RatioN/A Current Ratio1.55 Quick Ratio1.55 Sales & Book Value Annual Sales$2.03 billion Price / Sales0.21 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book1.48Miscellaneous Outstanding Shares495,290,000Free Float387,219,000Market Cap$433.43 million OptionableOptionable Beta1.88 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Vivek Garipalli (Age 45)Co-Founder & Executive Chairman Mr. Andrew Toy (Age 45)Co-Founder, CEO & Director Comp: $1.01MMr. Brady Priest J.D. (Age 47)Chief Executive Officer of Home Care Comp: $587.36kMr. Terrence Ronan (Age 64)Interim CFO, Principal Financial Officer & Principal Accounting Officer Mr. Conrad Wai (Age 43)Chief Technology Officer Mr. Derrick L. NuemanHead of Investor Relations & Corporate strategyMs. Wendy RicheyChief Compliance OfficerMs. Karen SoaresGeneral Counsel, Senior VP & Corporate SecretaryMs. Rachel FishChief People OfficerMs. Jamie L. Reynoso (Age 54)Chief Executive Officer of Medicare Advantage Comp: $461.74kMore ExecutivesKey CompetitorsSkillzNYSE:SKLZDragoneer Growth OpportunitiesNYSE:DGNRAlignment HealthcareNASDAQ:ALHCPulmonxNASDAQ:LUNGAurora CannabisNASDAQ:ACBView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 6,633,026 shares on 5/10/2024Ownership: 3.573%Jupiter Asset Management Ltd.Bought 692,878 shares on 5/10/2024Ownership: 0.914%Allspring Global Investments Holdings LLCBought 46,912 shares on 4/30/2024Ownership: 0.016%Simplex Trading LLCBought 179,800 shares on 4/25/2024Ownership: 0.000%Allspring Global Investments Holdings LLCBought 46,912 shares on 4/18/2024Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions CLOV Stock Analysis - Frequently Asked Questions Should I buy or sell Clover Health Investments stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. View CLOV analyst ratings or view top-rated stocks. What is Clover Health Investments' stock price target for 2024? 1 brokers have issued twelve-month price targets for Clover Health Investments' shares. Their CLOV share price targets range from $1.50 to $1.50. On average, they predict the company's share price to reach $1.50 in the next year. This suggests a possible upside of 64.5% from the stock's current price. View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts. How have CLOV shares performed in 2024? Clover Health Investments' stock was trading at $0.9521 on January 1st, 2024. Since then, CLOV shares have decreased by 4.2% and is now trading at $0.9117. View the best growth stocks for 2024 here. When is Clover Health Investments' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our CLOV earnings forecast. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) announced its quarterly earnings data on Tuesday, March, 12th. The company reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.06. The firm earned $510.25 million during the quarter, compared to the consensus estimate of $491.20 million. Clover Health Investments had a negative trailing twelve-month return on equity of 48.07% and a negative net margin of 8.63%. Who are Clover Health Investments' major shareholders? Clover Health Investments' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.57%), Jupiter Asset Management Ltd. (0.91%), Simplex Trading LLC (0.00%), SignalPoint Asset Management LLC (0.03%), Allspring Global Investments Holdings LLC (0.02%) and Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CLOV) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithMillionaire investor and Republican donor makes surprising election predictionInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
